Interface Cardiotomy Blood Filter
Medical
FDA Clearance Information
The interface cardiotomy blood filter was cleared via the FDA 510(k) pathway on September 27, 1978. It is manufactured by Medical and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Filtering blood during cardiopulmonary bypass
- Removing air and particulate matter from blood in the cardiopulmonary bypass circuit
Clinical Applications
- Use during coronary artery bypass grafting when cardiopulmonary bypass is required
- Use during cardiac surgery requiring extracorporeal circulation
- Filtration of blood returning to the cardiopulmonary bypass system
- Air and particulate removal as part of intraoperative blood management
Practical Considerations
- The filter must be correctly integrated into a compatible cardiopulmonary bypass or perfusion circuit.
- Clinicians should confirm the device size, connection type, priming requirements, and allowable flow rate before use.
- The filter is intended for use by trained cardiac surgical and perfusion personnel under the product labeling and institutional protocols.
- Inspect the device and circuit for leaks, air, damage, or incorrect connections before initiating bypass.
- This is an extracorporeal blood-circuit component, not an implantable device; MRI considerations generally relate to the complete perfusion setup and any attached components.
Related Literature
Frequently Asked Questions
What is the interface cardiotomy blood filter used for?
It is used to filter blood during cardiopulmonary bypass, removing air and particulates to prevent embolic events.
What specialties typically use this device?
Cardiac surgery and perfusion specialties typically use this device in operating rooms during bypass procedures.
What are the FDA-cleared indications?
It is indicated for filtering blood during cardiopulmonary bypass to remove air and particulates in patients undergoing cardiac surgery.